EBV persistence without its EBNA3A and 3C oncogenes in vivo

MLA

Martin J. Allday, et al. “EBV Persistence without Its EBNA3A and 3C Oncogenes in Vivo.” PLoS Pathogens, vol. 14, no. 4, Feb. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....262c57930e50a5ef5d52c4828fdc5314&authtype=sso&custid=ns315887.

APA

Martin J. Allday, Gerald Niedobitek, Donal McHugh, Christian Münz, Mário Henrique M. Barros, Jens Kalchschmidt, Obinna Chijioke, Riccarda Capaul, Anita Murer, Nicole Caduff, & Andrea Zbinden. (2018). EBV persistence without its EBNA3A and 3C oncogenes in vivo. PLoS Pathogens, 14(4).

Chicago

Martin J. Allday, Gerald Niedobitek, Donal McHugh, Christian Münz, Mário Henrique M. Barros, Jens Kalchschmidt, Obinna Chijioke, et al. 2018. “EBV Persistence without Its EBNA3A and 3C Oncogenes in Vivo.” PLoS Pathogens 14 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....262c57930e50a5ef5d52c4828fdc5314&authtype=sso&custid=ns315887.